These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 4067823)

  • 1. [Crystallinity changes of alpha- and beta-cyclodextrins by grinding].
    Nakai Y; Yamamoto K; Terada K; Kajiyama A
    Yakugaku Zasshi; 1985 Jun; 105(6):580-5. PubMed ID: 4067823
    [No Abstract]   [Full Text] [Related]  

  • 2. [Stability test of chloramphenicol-beta-cyclodextrin-containing tablets].
    Szabó-Révész P; Pintye-Hódi K; Miseta M; Selmeczi B
    Pharmazie; 1988 Aug; 43(8):554-5. PubMed ID: 3237749
    [No Abstract]   [Full Text] [Related]  

  • 3. Influencing of resorption and side-effects of salicylic acid by complexing with beta-cyclodextrin.
    Szejtli J; Gerlóczy A; Sebestyén G; Fónagy A
    Pharmazie; 1981 Apr; 36(4):283-6. PubMed ID: 7255530
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Identification of Fritillaria herbal drugs by X-ray diffraction of starch grains].
    Wang SJ; Gao WY; Yu JG; Xiao PG
    Zhongguo Zhong Yao Za Zhi; 2005 Jun; 30(11):805-7. PubMed ID: 16110855
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Spray embedding of vinpocetin with beta-cyclodextrin].
    Kata M; György E
    Pharmazie; 1982 May; 37(5):386-7. PubMed ID: 7111372
    [No Abstract]   [Full Text] [Related]  

  • 6. [Use of a sulfamethoxazole-beta-cyclodextrin complex in suppositories].
    Tóth K; Apostol I
    Acta Pharm Hung; 1986 May; 56(3):133-7. PubMed ID: 3739726
    [No Abstract]   [Full Text] [Related]  

  • 7. [Beta-cyclodextrin as an auxiliary substance in tabletting (preliminary communication)].
    Krajnyák J; Rácz I; Dávid A; Szejtli J
    Acta Pharm Hung; 1984 Mar; 54(2):90-1. PubMed ID: 6730980
    [No Abstract]   [Full Text] [Related]  

  • 8. [Molecular cavity filling and tabletting with beta-cyclodextrin].
    Hüttenrauch R; Fricke S
    Pharmazie; 1985 May; 40(5):361-2. PubMed ID: 4034643
    [No Abstract]   [Full Text] [Related]  

  • 9. [Stabilization of chlorobutanol with beta-cyclodextrin in suppositories].
    Gyulai M; Apostol I
    Acta Pharm Hung; 1986 May; 56(3):125-8. PubMed ID: 3739724
    [No Abstract]   [Full Text] [Related]  

  • 10. Relationships between crystallinity of beta-cyclodextrin and tablet characteristics.
    Nakai Y; Yamamoto K; Terada K; Kajiyama A
    Chem Pharm Bull (Tokyo); 1985 Nov; 33(11):5110-2. PubMed ID: 3830437
    [No Abstract]   [Full Text] [Related]  

  • 11. The potential use of cyclodextrins in parenteral formulations.
    Aquino S; Quach N; Richardson C; McDonald C
    J Parenter Sci Technol; 1990; 44(2):48-9. PubMed ID: 2338603
    [No Abstract]   [Full Text] [Related]  

  • 12. Preparation and investigation of hydrochlorothiazide products containing beta-cyclodextrin.
    Kata M; Lukács M
    Pharmazie; 1984 Dec; 39(12):857-8. PubMed ID: 6531397
    [No Abstract]   [Full Text] [Related]  

  • 13. [Benzylisoquinoline alkaloid reactions with barbiturates. Reaction of papaverine with sodium phenobarbital. III. Avoidance of incompatibility by using the beta-cyclodextrin inclusion complex].
    Rácz I; Plachy J; Szabóné Tábori M; Stadlerné Szöke A; Vikmon M; Szejtli J
    Acta Pharm Hung; 1984 Jul; 54(4):154-9. PubMed ID: 6485810
    [No Abstract]   [Full Text] [Related]  

  • 14. Crystal structure of the gamma-cyclodextrin n-propanol inclusion complex; correlation of alpha-, beta-, gamma- cyclodextrin geometries.
    Lindner K; Saenger W
    Biochem Biophys Res Commun; 1980 Feb; 92(3):933-8. PubMed ID: 7362616
    [No Abstract]   [Full Text] [Related]  

  • 15. Stereochemistry of circularly closed oligosaccharides: cyclodextrin structure and function.
    Saenger W
    Biochem Soc Trans; 1983 Apr; 11 Pt 2():136-9. PubMed ID: 6873451
    [No Abstract]   [Full Text] [Related]  

  • 16. [Inclusion complexation of p-hydroxybenzoic acid esters with alpha- and beta-cyclodextrins: dissolution behaviors and antimicrobial activities (author's transl)].
    Uekama K; Ikeda Y; Hirayama F; Otagiri M; Shibata M
    Yakugaku Zasshi; 1980 Oct; 100(10):994-1003. PubMed ID: 7218148
    [No Abstract]   [Full Text] [Related]  

  • 17. Enhancement of solubility of furosemide with beta-cyclodextrin.
    Kata M; Antal A
    Pharmazie; 1984 Dec; 39(12):856-7. PubMed ID: 6531396
    [No Abstract]   [Full Text] [Related]  

  • 18. Enhancement of stability and biological effect on cholecalciferol by beta-cyclodextrin complexation.
    Szejtli J; Bolla-Pusztai E; Szabó P; Ferenczy T
    Pharmazie; 1980 Dec; 35(12):779-87. PubMed ID: 6259671
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparative study on inclusion complexation of beta-cyclodextrin and tri-O-methyl-beta-cyclodextrin with several drugs in aqueous solution.
    Otagiri M; Uekama K; Imai T; Maeda T; Takadate A; Goya S; Janssen LH
    Acta Pharm Suec; 1984; 21(6):357-66. PubMed ID: 6534072
    [No Abstract]   [Full Text] [Related]  

  • 20. Dissolution behavior of prednisolone from solid dispersion systems with cyclodextrins and polyvinylpyrrolidone.
    Fukuda N; Higuchi N; Ohno M; Kenmochi H; Sekikawa H; Takada M
    Chem Pharm Bull (Tokyo); 1986 Mar; 34(3):1366-9. PubMed ID: 3731351
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.